Keyphrases
Anticancer Immune Response
9%
Biomarker Combination
27%
Biomarker Profile
100%
Biomarkers of Response
9%
Cancer Cells
9%
Chemoradiation
36%
Colorectal Cancer
100%
Cyclin D1 G870A
18%
Epigenetic Biomarkers
9%
Kirsten Rat Sarcoma Viral Oncogene Homolog
27%
Locally Advanced Rectal Cancer
18%
Methylenetetrahydrofolate Reductase (MTHFR)
18%
Minimal Responses
9%
MTHFR C677T
18%
NAD(P)
18%
Neoadjuvant Chemoradiotherapy (nCRT)
100%
Oncologic Therapy
9%
Pathological Complete Response
100%
Polymorphism
54%
Positive Predictive Value
9%
Ras2
27%
Specific Biomarkers
9%
Surgical Specimen
18%
Tumor Biopsy
9%
Tumor Control
9%
Tumor DNA
9%
Tumor Protein p53 (TP53)
9%
Tumor Response
27%
Medicine and Dentistry
Biological Marker
100%
Cancer Cell
12%
Chemoradiation Therapy
100%
Chemoradiotherapy
75%
Cyclin D1
25%
Methylenetetrahydrofolate Reductase
25%
Neoplasm
50%
Protein P53
37%
Rectum Cancer
100%
Sarcoma
37%
Tumor Biopsy
12%
Tumor Protein
12%
Virus Oncogene
37%
Pharmacology, Toxicology and Pharmaceutical Science
5,10 Methylenetetrahydrofolate Reductase (FADH2)
25%
Biological Marker
100%
Chemoradiation Therapy
100%
Cyclin D1
25%
Malignant Neoplasm
12%
Neoplasm
62%
Protein P53
37%
Rectum Cancer
100%
Sarcoma
37%
Tumor Protein
12%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
33%
Cyclin D1
66%
Genetics
33%
Methylenetetrahydrofolate Reductase
66%
P53
100%
Ras2
100%
Virus Oncogene
100%